Unlock a more sustainable way to eat by welcoming back nutrient-dense staples that have been unfairly maligned by outdated ...

As we age, we don't recover from injury or illness like we did when we were young. But new research from UC San Francisco has ...

The peptide known as BPC‑157 (pentadecapeptide BPC-157) has garnered increasing attention across research domains ...

Researchers have developed a nanoparticle platform that can deliver mRNA therapy to affected cartilage based on ...

Ferring Pharmaceuticals and Theralase® Technologies Inc. are pleased to announce that they have entered into a collaborative clinical development agreement ("Agreement") on January 9, 2026. The ...

In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...